ATOSSA THERAPEUTICS, INC. — Director's Dealing 2024

Jul 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA THERAPEUTICS, INC. (ATOS)
CIK: 0001488039
Period of Report: 2024-06-27

Reporting Person: Remmel H. Lawrence (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-27	Stock Option (right to buy)	$1.05	A	125000	Acquired	2034-06-27	Common Stock (125000)	Direct

Footnotes

F1: The options shall vest on a quarterly basis over 12 months following June 27, 2024, subject to the Reporting Person's continued service through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024 with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024.